Skip to content

Validation of a Sensor for Non-Invasive Measurements

Validation of a Sensor for Non-Invasive Measurement of Vital Signs, Hemodynamic Parameters and Time-Dependent Physiological Waveforms

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03463148
Enrollment
136
Registered
2018-03-13
Start date
2017-10-24
Completion date
2021-04-19
Last updated
2022-01-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

CHF, Hypertension, Renal Disease

Brief summary

Subjects will be measured with both a sensor and a reference device

Detailed description

Subjects will participate in a study measuring a single set of paired values. In this case, measurements will take roughly 2-30 minutes to complete, and will involve: 1) attaching the sensor on the subject; 2) attaching one or more reference devices to the subject; 3) making measurements with both the sensor and reference device, either simultaneously or sequentially; and 4) collecting and analyzing the paired value.

Interventions

None listed

Sponsors

Baxter Healthcare Corporation
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

1. Subject is at least 18 (eighteen) years of age at screening. 2. Subject and/or legally authorized person/representative is willing to undergo the Informed Consent process prior to enrollment in the study. 3. Subject selection will not be based on age, height, or weight. 4. Subject is a candidate for this study based on the PI's opinion and knowledge of the subject's condition as well as the features of the investigational device tested during the study.

Exclusion criteria

1. Subject is participating in another clinical study that may affect the results of either study. 2. Subjects that are pregnant will not be included in the study. 3. Subject is unable or not willing to wear electrode patches as required for a period of up to 168 hours. 4. Subject is considered by the Principal Investigator to be medically unsuitable for study participation.

Design outcomes

Primary

MeasureTime frameDescription
Comparison of Blood Pressure Measurement from Sensor with Human Auscultation measurement of Blood Pressure.3-36 MonthsComparison of Blood Pressure Measurement from Sensor with Human Auscultation measurement of Blood Pressure. Specifically, Systolic Blood Pressure and Diastolic Blood Pressure with units of millimeters of mercury (mmHg) will be compared.
Fluids3-36 MonthsObservation of fluid measurement from Sensor (ohms)
Heart Rate3-36 MonthsObservation of heart rate measurement from Sensor (beats/min)
Heart Rate Variability3-36 MonthsObservation of heart rate variability from Sensor (milliseconds)
Respiration Rate3-36 MonthsObservation of respiration rate from Sensor (breaths/min)

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026